Nan Shan Life gets low bids
The sale of Nan Shan Life, insurer American Intermediate Group’s Taiwanese subsidiary, may not go-ahead after three bidders submitted offers for less than $1.5bn — way below the $2bn the insurer had expected.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts